These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7084079)

  • 41. [Concerning the evaluation of different therapies in obesity (author's transl)].
    Kreze A; Toman A
    Bratisl Lek Listy; 1974 Nov; 62(5):559-63. PubMed ID: 4434219
    [No Abstract]   [Full Text] [Related]  

  • 42. [Obesity. An unsolved problem in practice].
    Hartmann G
    ZFA (Stuttgart); 1981 Jan; 57(2):79-86. PubMed ID: 7210829
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunoreactive insulin and obesity (author's transl)].
    Rath R; Slabochová Z
    Bratisl Lek Listy; 1975 Oct; 64(4):385-93. PubMed ID: 1182567
    [No Abstract]   [Full Text] [Related]  

  • 44. [Symposium on gastrointestinal hormones. Enteroglucagon: with special reference to changes in concentration in the circulation (author's transl)].
    Shima K
    Nihon Naika Gakkai Zasshi; 1974 Sep; 63(9):1052-7. PubMed ID: 4474347
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the determination of the glucagon content in plasma extracts].
    MAGGI G; ANDREIS G
    Arch Sci Med (Torino); 1960 Oct; 110():406-18. PubMed ID: 13765215
    [No Abstract]   [Full Text] [Related]  

  • 46. [Quantitative determination of glucagon in the blood: methodological controls].
    MAGGI G
    Arch Sci Med (Torino); 1960 Jan; 109():9-22. PubMed ID: 14419807
    [No Abstract]   [Full Text] [Related]  

  • 47. [Glucagon].
    SCURO LA
    Policlinico Prat; 1958 Apr; 65(14):553-6. PubMed ID: 13553847
    [No Abstract]   [Full Text] [Related]  

  • 48. [Glucagon].
    FRANCK C
    Rev Med Nancy; 1957 Nov; 82():1089-110. PubMed ID: 13495018
    [No Abstract]   [Full Text] [Related]  

  • 49. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?
    Niederau C; Berger M; Stremmel W; Starke A; Strohmeyer G; Ebert R; Siegel E; Creutzfeldt W
    Diabetologia; 1984 Jun; 26(6):441-4. PubMed ID: 6381191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjects.
    Bonora E; Moghetti P; Cacciatori V; Zenere M; Tosi F; Travia D; Zoppini G; Perobelli L; Muggeo M
    Acta Diabetol Lat; 1990; 27(4):309-14. PubMed ID: 1982386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
    Emara MK; Saadah A; Hassan M; Moussa M; Hourani H
    Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
    J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fasting and postprandial plasma glucagon and glucagon-like immunoreactivity are normal in obese Pima Indians.
    Vasquez B; Nagulesparan M; Unger RH
    Horm Metab Res; 1983 May; 15(5):218-20. PubMed ID: 6347855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance.
    Glaser B; Zoghlin G; Pienta K; Vinik AI
    Horm Metab Res; 1988 May; 20(5):288-92. PubMed ID: 3042579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Raised plasma glucagon levels in obesity (author's transl)].
    Starke A; Starke G; Jörgens V; Berger M; Zimmermann H
    Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1125-8. PubMed ID: 7084079
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.